Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06161948
Other study ID # 2023AH040243
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 1, 2024
Est. completion date October 1, 2025

Study information

Verified date October 2023
Source First Affiliated Hospital of Wannan Medical College
Contact Tao Yu, doctor
Phone 18855392038
Email dryutao2022@163.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In patients with severe stroke whose GCS score is ≤12 points or NIHSS score is ≥11 points, to evaluate whether time-restricted enteral nutrition can improve the incidence of poor 90-day prognosis (mRS ≥3 points) compared with continuous enteral nutrition.


Description:

Control the daily enteral nutrition time to 8-12 hours, enteral nutrition start time: 06:00 ~ 08:00, end time: 16:00 ~ 18:00. Enteral nutrition lasts until the patient discontinues enteral nutrition, the patient dies, the patient is transferred from the ICU, or enteral nutrition is used until 28 days, whichever event occurs first. On the first day of enrollment: the patient is given 1/3 of the estimated energy and 1.2-1.5g/kg/d of protein through enteral nutrition; On the second day of enrollment: the patient is given 1/2 of the estimated energy and 1.2-1.5g/kg/d of protein through enteral nutrition; Enrollment 3 - End of intervention: The patient is given 100% of the estimated energy through enteral nutrition, which can fluctuate between 70% and 100% of the estimated energy, and the protein is 1.2-1.5g/kg/d. The control group was continuous enteral nutrition (24 hours), which lasted until the patient stopped taking enteral nutrition, the patient died, the patient was transferred from the ICU, or enteral nutrition was used until 28 days, whichever event occurred first. On the first day of enrollment: the patient is given 1/3 of the estimated energy and 1.2-1.5g/kg/d of protein through enteral nutrition; On the second day of enrollment: the patient is given 1/2 of the estimated energy and 1.2-1.5g/kg/d of protein through enteral nutrition; Enrollment 3 - End of intervention: The patient is given 100% of the estimated energy through enteral nutrition, which can fluctuate between 70% and 100% of the estimated energy, and the protein is 1.2-1.5g/kg/d.


Recruitment information / eligibility

Status Recruiting
Enrollment 420
Est. completion date October 1, 2025
Est. primary completion date March 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Age =18 years old and <80 years old; - Cerebral parenchymal hemorrhage or cerebral infarction within 72 hours of onset; - GCS score =12 points or NIHSS score =11 points on admission, - Enteral nutrition is planned, and the estimated enteral nutrition treatment time is =7 days; - Signed informed consent form. Exclusion Criteria: - Complete parenteral nutrition is required due to contraindications to enteral nutrition; - After gastrectomy or intestinal resection; - Enteral nutrition treatment has been performed for >12 hours; - Accompanying diseases: a. Advanced cancer; b. Severe cardiac insufficiency [ejection fraction = 50%]; c. Severe liver failure [Child Pugh score = 7]; d. Severe renal failure [glomerular filtration] rate = 30 mL/min or serum creatinine = 4 mg/dL]) - Have a history of mental illness or mRS = 3 points; - The patient's doctor or nutritional therapist believes that the plan is not in the best interest of the patient; - During the patient's admission, death is inevitable, and there are underlying diseases that result in a survival time of <90 days; - The patient participates in another clinical study.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Time-restricted enteral nutrition therapy group
Control the daily enteral nutrition time to 8-12 hours, enteral nutrition start time: 06:00 ~ 08:00, end time: 16:00 ~ 18:00. Enteral nutrition lasts until the patient discontinues enteral nutrition, the patient dies, the patient is transferred from the ICU, or enteral nutrition is used until 28 days, whichever event occurs first.
Continuous enteral nutrition control group
The control group was continuous enteral nutrition (24 hours), which lasted until the patient stopped taking enteral nutrition, the patient died, the patient was transferred from the ICU, or enteral nutrition was used until 28 days, whichever event occurred first.

Locations

Country Name City State
China The first affliated hospital of Wannan medical college Wuhu

Sponsors (1)

Lead Sponsor Collaborator
First Affiliated Hospital of Wannan Medical College

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Poor 90-day functional prognosis mRS = 3 points 90-day
Secondary GCS score at discharge Glasgow Coma Scale,the score ranges from 3-15. The lower the score, the greater the impairment of consciousness average of 32-day
Secondary NIHSS score at discharge NIH Stroke Scale,the score ranges from 0~42 points, and the higher the score, the more severe the nerve damage average of 32-day
Secondary mRS score at discharge Modified Rankin Scale,the score ranges from 0~6 levels,and the higher the score, the more severe outcome average of 32-day
Secondary Barthel index at discharge Barthel index at discharge average of 32-day
Secondary 90-day Barthel Index 90-day Barthel Index 90-day
Secondary ICU length of stay ICU length of stay 13-day
Secondary total length of stay total length of stay average of 32-day
Secondary Nutritional status albumin, prealbumin, hemoglobin, transferrin levels 7-day,14-day,28-day
Secondary Electrolyte levels serum potassium, serum sodium, serum phosphorus, serum magnesium levels 7-day,14-day,28-day
See also
  Status Clinical Trial Phase
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Suspended NCT03869138 - Alternative Therapies for Improving Physical Function in Individuals With Stroke N/A
Completed NCT04034069 - Effects of Priming Intermittent Theta Burst Stimulation on Upper Limb Motor Recovery After Stroke: A Randomized Controlled Trial N/A
Completed NCT04101695 - Hemodynamic Response of Anodal Transcranial Direct Current Stimulation Over the Cerebellar Hemisphere in Healthy Subjects N/A
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Completed NCT00391378 - Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS) N/A
Recruiting NCT06204744 - Home-based Arm and Hand Exercise Program for Stroke: A Multisite Trial N/A
Active, not recruiting NCT06043167 - Clinimetric Application of FOUR Scale as in Treatment and Rehabilitation of Patients With Acute Cerebral Injury
Enrolling by invitation NCT04535479 - Dry Needling for Spasticity in Stroke N/A
Completed NCT03985761 - Utilizing Gaming Mechanics to Optimize Telerehabilitation Adherence in Persons With Stroke N/A
Recruiting NCT00859885 - International PFO Consortium N/A
Recruiting NCT06034119 - Effects of Voluntary Adjustments During Walking in Participants Post-stroke N/A
Completed NCT03622411 - Tablet-based Aphasia Therapy in the Chronic Phase N/A
Completed NCT01662960 - Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke N/A
Recruiting NCT05854485 - Robot-Aided Assessment and Rehabilitation of Upper Extremity Function After Stroke N/A
Active, not recruiting NCT05520528 - Impact of Group Participation on Adults With Aphasia N/A
Active, not recruiting NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Completed NCT05805748 - Serious Game Therapy in Neglect Patients N/A
Recruiting NCT05993221 - Deconstructing Post Stroke Hemiparesis